Valeant Pharmaceuticals acquires DermaTech

Aliso Viejo, Calif.

- Valeant Pharmaceuticals has announced it has acquired DermaTech, an Australian pharmaceutical company focused on dermatology products, for AU$19 million, marketwatch reports.

The transaction will expand Valeant’s specialty pharmaceutical portfolio through the acquisition of key products,according to the company.